from pg 13 AR
"In June 2021, NEXTSTELLIS was launched into the US market and
is being supported by a highly experienced national women’s
health sales team. By August 2021, the sales team had held 20,000
in-person interactions with prescribers and reached more than
60% of priority prescriber targets."
Suggests there are about 33k priority prescribers in the US. The message is getting out - these docs have better things to do than talk about something of little interest. Assuming Mayne are not counting hang ups and line clicks - lol!
Add to My Watchlist
What is My Watchlist?
